title: Reduced acute rejection after liver transplantation with Neoral-based triple immunosuppression.
authors.forename: D F
authors.initials: DF
authors.lastname: Mirza
authors.forename: B K
authors.initials: BK
authors.lastname: Gunson
authors.forename: Z
authors.initials: Z
authors.lastname: Soonawalla
authors.forename: J
authors.initials: J
authors.lastname: Pirenne
authors.forename: A D
authors.initials: AD
authors.lastname: Mayer
authors.forename: J A
authors.initials: JA
authors.lastname: Buckels
authors.forename: P
authors.initials: P
authors.lastname: McMaster
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D016572:Cyclosporine / Q000008:administration & dosage / Q000627:therapeutic use*; D004361:Drug Tolerance; D004655:Emulsions; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D007902:Length of Stay; D016031:Liver Transplantation; D008875:Middle Aged; D016559:Tacrolimus / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D004655:Emulsions; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus